_id
69148911ccc777a4e85d9823
Ticker
OSRH
Name
OSR Holdings Inc
Exchange
NASDAQ
Address
10900 NE 4th Street, Bellevue, WA, United States, 98004
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.osr-holdings.com
Description
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.
Last Close
0.582
Volume
404960
Current Price
0.7167
Change
-0.0005
Last Updated
2026-01-06T08:43:55.385Z
Image
data:image/webp;base64,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
Ipo Date
2023-03-17T00:00:00.000Z
Market Cap
15131541
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9950000000000001
Sentiment Sources
3
Current Quarter
2025-09-30
Revenue
627747
Cost Of Revenue
366013
Gross Profit
261734
Operating Expenses
4065199
Operating Income
-3803465
Interest Expense
43866
Pretax Income
-4489826
Net Income
-3194874
Eps
-0.15023424770583962
Dividends Per Share
-
Shares Outstanding
25672788
Income Tax Expense
-1294952
EBITDA
-2059214
Operating Margin
-605.891386179464
Total Other Income Expense Net
-686361
Cash
2177309
Short Term Investments
0
Receivables
533929
Inventories
185095
Total Current Assets
3204215
Property Plant Equipment
148480
Total Assets
177289528
Payables
7663482
Short Term Debt
4368652
Long Term Debt
-
Total Liabilities
43131683
Equity
81945185
Bs_currency_symbol
USD
Depreciation
2386746
Change In Working Capital
-1270624
Cash From Operations
-2711365
Capital Expenditures
2711365
Cash From Investing
-726632
Cash From Financing
4115717
Net Change In Cash
592903
Cf_currency_symbol
USD
PE
-
PB
0.18599392221763852
ROE
-3.8987940536103496
ROA
-1.8020658275992478
FCF
-5422730
Fcf Percent
-8.638400502113113
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
5
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
627747
Quarters > 0 > income Statement > cost Of Revenue
366013
Quarters > 0 > income Statement > gross Profit
261734
Quarters > 0 > income Statement > operating Expenses
4065199
Quarters > 0 > income Statement > operating Income
-3803465
Quarters > 0 > income Statement > interest Expense
43866
Quarters > 0 > income Statement > pretax Income
-4489826
Quarters > 0 > income Statement > net Income
-3194874
Quarters > 0 > income Statement > eps
-0.15023424770583962
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
21265950
Quarters > 0 > income Statement > income Tax Expense
-1294952
Quarters > 0 > income Statement > EBITDA
-2059214
Quarters > 0 > income Statement > operating Margin
-605.891386179464
Quarters > 0 > income Statement > total Other Income Expense Net
-686361
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
2177309
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
533929
Quarters > 0 > balance Sheet > inventories
185095
Quarters > 0 > balance Sheet > total Current Assets
3204215
Quarters > 0 > balance Sheet > property Plant Equipment
148480
Quarters > 0 > balance Sheet > total Assets
177289528
Quarters > 0 > balance Sheet > payables
7663482
Quarters > 0 > balance Sheet > short Term Debt
4368652
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
43131683
Quarters > 0 > balance Sheet > equity
81945185
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2126595
Quarters > 0 > cash Flow > depreciation
2386746
Quarters > 0 > cash Flow > change In Working Capital
-1270624
Quarters > 0 > cash Flow > cash From Operations
-2711365
Quarters > 0 > cash Flow > capital Expenditures
2711365
Quarters > 0 > cash Flow > cash From Investing
-726632
Quarters > 0 > cash Flow > cash From Financing
4115717
Quarters > 0 > cash Flow > net Change In Cash
592903
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.15023424770583962
Quarters > 0 > ratios > PB
0.18599392221763852
Quarters > 0 > ratios > ROE
-3.8987940536103496
Quarters > 0 > ratios > ROA
-1.8020658275992478
Quarters > 0 > ratios > FCF
-5422730
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-8.638400502113113
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1135517
Quarters > 1 > income Statement > cost Of Revenue
1102735
Quarters > 1 > income Statement > gross Profit
32782
Quarters > 1 > income Statement > operating Expenses
5261959
Quarters > 1 > income Statement > operating Income
-5229177
Quarters > 1 > income Statement > interest Expense
36930
Quarters > 1 > income Statement > pretax Income
-5225198
Quarters > 1 > income Statement > net Income
331414
Quarters > 1 > income Statement > eps
0.02
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
16570700
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2836668
Quarters > 1 > income Statement > operating Margin
-460.51067487320756
Quarters > 1 > income Statement > total Other Income Expense Net
3979
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
1584406
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
751245
Quarters > 1 > balance Sheet > inventories
198827
Quarters > 1 > balance Sheet > total Current Assets
2875177
Quarters > 1 > balance Sheet > property Plant Equipment
90629
Quarters > 1 > balance Sheet > total Assets
185415021
Quarters > 1 > balance Sheet > payables
7559067
Quarters > 1 > balance Sheet > short Term Debt
4275644
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
46261975
Quarters > 1 > balance Sheet > equity
83702390
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
331414
Quarters > 1 > cash Flow > depreciation
2351600
Quarters > 1 > cash Flow > change In Working Capital
1720282
Quarters > 1 > cash Flow > cash From Operations
-482607
Quarters > 1 > cash Flow > capital Expenditures
2683
Quarters > 1 > cash Flow > cash From Investing
-528424
Quarters > 1 > cash Flow > cash From Financing
891482
Quarters > 1 > cash Flow > net Change In Cash
-11291
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.02
Quarters > 1 > ratios > PB
0.1418862793523578
Quarters > 1 > ratios > ROE
0.3959432938533774
Quarters > 1 > ratios > ROA
0.17874172125461185
Quarters > 1 > ratios > FCF
-485290
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.4273736104347183
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
761272
Quarters > 2 > income Statement > cost Of Revenue
592586
Quarters > 2 > income Statement > gross Profit
168686
Quarters > 2 > income Statement > operating Expenses
3086512
Quarters > 2 > income Statement > operating Income
-2917826
Quarters > 2 > income Statement > interest Expense
16399
Quarters > 2 > income Statement > pretax Income
-11392814
Quarters > 2 > income Statement > net Income
-11392814
Quarters > 2 > income Statement > eps
-1.0446372638914359
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
10906000
Quarters > 2 > income Statement > income Tax Expense
71966
Quarters > 2 > income Statement > EBITDA
-9103220
Quarters > 2 > income Statement > operating Margin
-383.2829790140712
Quarters > 2 > income Statement > total Other Income Expense Net
-8474988
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1595697
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
799536
Quarters > 2 > balance Sheet > inventories
736630
Quarters > 2 > balance Sheet > total Current Assets
3466839
Quarters > 2 > balance Sheet > property Plant Equipment
69593
Quarters > 2 > balance Sheet > total Assets
174550197
Quarters > 2 > balance Sheet > payables
7296793
Quarters > 2 > balance Sheet > short Term Debt
4499685
Quarters > 2 > balance Sheet > long Term Debt
253042
Quarters > 2 > balance Sheet > total Liabilities
42267719
Quarters > 2 > balance Sheet > equity
75759964
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-11392814
Quarters > 2 > cash Flow > depreciation
2273195
Quarters > 2 > cash Flow > change In Working Capital
430285
Quarters > 2 > cash Flow > cash From Operations
-64069
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
1185591
Quarters > 2 > cash Flow > cash From Financing
149381
Quarters > 2 > cash Flow > net Change In Cash
1254154
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.0446372638914359
Quarters > 2 > ratios > PB
0.10317230615368297
Quarters > 2 > ratios > ROE
-15.03804040878372
Quarters > 2 > ratios > ROA
-6.526955681407796
Quarters > 2 > ratios > FCF
-64069
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.08416045776016982
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-2615051
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
2144092
Quarters > 3 > income Statement > operating Income
-2144092
Quarters > 3 > income Statement > interest Expense
43011
Quarters > 3 > income Statement > pretax Income
-1950227
Quarters > 3 > income Statement > net Income
-2022193
Quarters > 3 > income Statement > eps
-0.8717280985208764
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
2319752
Quarters > 3 > income Statement > income Tax Expense
71966
Quarters > 3 > income Statement > EBITDA
-1907216
Quarters > 3 > income Statement > operating Margin
81.99044684023372
Quarters > 3 > income Statement > total Other Income Expense Net
193865
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
66135
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
300000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
455398
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
2303041
Quarters > 3 > balance Sheet > payables
2882012
Quarters > 3 > balance Sheet > short Term Debt
2563000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
8788809
Quarters > 3 > balance Sheet > equity
-6485768
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2022193
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
1753982
Quarters > 3 > cash Flow > cash From Operations
-502905
Quarters > 3 > cash Flow > capital Expenditures
4
Quarters > 3 > cash Flow > cash From Investing
18973071
Quarters > 3 > cash Flow > cash From Financing
-18416266
Quarters > 3 > cash Flow > net Change In Cash
53899
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.8717280985208764
Quarters > 3 > ratios > PB
-0.2563406921740031
Quarters > 3 > ratios > ROE
31.17892900270253
Quarters > 3 > ratios > ROA
-87.80534085150894
Quarters > 3 > ratios > FCF
-502909
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
0.19231326654814762
Quarters > 3 > health Score
48
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
3524549
Annuals > 0 > income Statement > operating Income
-3524549
Annuals > 0 > income Statement > interest Expense
43011
Annuals > 0 > income Statement > pretax Income
-2115151
Annuals > 0 > income Statement > net Income
-2410879
Annuals > 0 > income Statement > eps
-0.5379024988844266
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
4482000
Annuals > 0 > income Statement > income Tax Expense
295728
Annuals > 0 > income Statement > EBITDA
-2072140
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
1409398
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
66135
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
300000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
455398
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
2303041
Annuals > 0 > balance Sheet > payables
2882012
Annuals > 0 > balance Sheet > short Term Debt
2563000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
8788809
Annuals > 0 > balance Sheet > equity
-6485768
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-2410879
Annuals > 0 > cash Flow > depreciation
10423000
Annuals > 0 > cash Flow > change In Working Capital
1673161
Annuals > 0 > cash Flow > cash From Operations
-2187946
Annuals > 0 > cash Flow > capital Expenditures
4
Annuals > 0 > cash Flow > cash From Investing
35907691
Annuals > 0 > cash Flow > cash From Financing
-33669029
Annuals > 0 > cash Flow > net Change In Cash
50716
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.5379024988844266
Annuals > 0 > ratios > PB
-0.40696025513092665
Annuals > 0 > ratios > ROE
37.17183531695861
Annuals > 0 > ratios > ROA
-104.68241772508608
Annuals > 0 > ratios > FCF
-2187950
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
2534486
Annuals > 1 > income Statement > gross Profit
921414
Annuals > 1 > income Statement > operating Expenses
1830700
Annuals > 1 > income Statement > operating Income
-1830700
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
944591
Annuals > 1 > income Statement > net Income
403780
Annuals > 1 > income Statement > eps
0.055018394876686194
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
7339000
Annuals > 1 > income Statement > income Tax Expense
540811
Annuals > 1 > income Statement > EBITDA
944591
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
2775291
Annuals > 1 > income Statement > currency_symbol
KRW
Annuals > 1 > balance Sheet > cash
15419
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
1543542712
Annuals > 1 > balance Sheet > inventories
1802614853
Annuals > 1 > balance Sheet > total Current Assets
22627
Annuals > 1 > balance Sheet > property Plant Equipment
235437968
Annuals > 1 > balance Sheet > total Assets
36627733
Annuals > 1 > balance Sheet > payables
1081753
Annuals > 1 > balance Sheet > short Term Debt
605829155
Annuals > 1 > balance Sheet > long Term Debt
460000000
Annuals > 1 > balance Sheet > total Liabilities
4108272
Annuals > 1 > balance Sheet > equity
32519461
Annuals > 1 > balance Sheet > currency_symbol
KRW
Annuals > 1 > cash Flow > net Income
403780
Annuals > 1 > cash Flow > depreciation
9714601
Annuals > 1 > cash Flow > change In Working Capital
1552745
Annuals > 1 > cash Flow > cash From Operations
-818766
Annuals > 1 > cash Flow > capital Expenditures
4
Annuals > 1 > cash Flow > cash From Investing
-33829815
Annuals > 1 > cash Flow > cash From Financing
34539499
Annuals > 1 > cash Flow > net Change In Cash
-109082
Annuals > 1 > cash Flow > currency_symbol
KRW
Annuals > 1 > ratios > PE
0.055018394876686194
Annuals > 1 > ratios > PB
0.13290309762514205
Annuals > 1 > ratios > ROE
1.2416564960901413
Annuals > 1 > ratios > ROA
1.102388728234969
Annuals > 1 > ratios > FCF
-818770
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
50
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
0
Annuals > 2 > income Statement > gross Profit
0
Annuals > 2 > income Statement > operating Expenses
35388
Annuals > 2 > income Statement > operating Income
-35388
Annuals > 2 > income Statement > interest Expense
14224
Annuals > 2 > income Statement > pretax Income
-35388
Annuals > 2 > income Statement > net Income
-35388
Annuals > 2 > income Statement > eps
-0.00416697085663821
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
8492500
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-35388
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1686000
Annuals > 2 > income Statement > currency_symbol
KRW
Annuals > 2 > balance Sheet > cash
2816404
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
505965
Annuals > 2 > balance Sheet > inventories
1078871
Annuals > 2 > balance Sheet > total Current Assets
4417562
Annuals > 2 > balance Sheet > property Plant Equipment
371600
Annuals > 2 > balance Sheet > total Assets
120757699
Annuals > 2 > balance Sheet > payables
4255843
Annuals > 2 > balance Sheet > short Term Debt
1187041
Annuals > 2 > balance Sheet > long Term Debt
126691.54
Annuals > 2 > balance Sheet > total Liabilities
21659379
Annuals > 2 > balance Sheet > equity
99098319
Annuals > 2 > balance Sheet > currency_symbol
KRW
Annuals > 2 > cash Flow > net Income
-35388
Annuals > 2 > cash Flow > depreciation
23246
Annuals > 2 > cash Flow > change In Working Capital
31153
Annuals > 2 > cash Flow > cash From Operations
-4235
Annuals > 2 > cash Flow > capital Expenditures
5
Annuals > 2 > cash Flow > cash From Investing
-1711335.38
Annuals > 2 > cash Flow > cash From Financing
123979
Annuals > 2 > cash Flow > net Change In Cash
119744
Annuals > 2 > cash Flow > currency_symbol
KRW
Annuals > 2 > ratios > PE
-0.00416697085663821
Annuals > 2 > ratios > PB
0.050467387342867036
Annuals > 2 > ratios > ROE
-0.03570999019670556
Annuals > 2 > ratios > ROA
-0.0293049638184974
Annuals > 2 > ratios > FCF
-4240
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
3308
Annuals > 3 > income Statement > operating Income
-3308
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-3308
Annuals > 3 > income Statement > net Income
-3308
Annuals > 3 > income Statement > eps
-0.00041926489226869456
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
7890000
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-3308
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
4757
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
4757
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
705087
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
400000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
707207
Annuals > 3 > balance Sheet > equity
-2120
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-3308
Annuals > 3 > cash Flow > depreciation
-
Annuals > 3 > cash Flow > change In Working Capital
2847
Annuals > 3 > cash Flow > cash From Operations
-461
Annuals > 3 > cash Flow > capital Expenditures
1
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-57435
Annuals > 3 > cash Flow > net Change In Cash
-57896
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-0.00041926489226869456
Annuals > 3 > ratios > PB
-2191.7080188679242
Annuals > 3 > ratios > ROE
156.03773584905662
Annuals > 3 > ratios > ROA
-0.4691619615735363
Annuals > 3 > ratios > FCF
-462
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
39
Valuation > metrics > PE
-0.15023424770583962
Valuation > metrics > PB
0.18599392221763852
Valuation > final Score
70
Valuation > verdict
81.4% Undervalued
Profitability > metrics > ROE
-3.8987940536103496
Profitability > metrics > ROA
-99.70847773947753
Profitability > metrics > Net Margin
-5.089429340164111
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5263479849365158
Risk > metrics > Interest Coverage
-86.70644690648794
Risk > final Score
-299
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.2663047968049558
Liquidity > metrics > Quick Ratio
0.250921407623951
Liquidity > final Score
23
Liquidity > verdict
Weak
Prev Valuations > 0
90
Prev Valuations > 1
70
Prev Valuations > 2
50
Prev Profitabilities > 0
61
Prev Profitabilities > 1
0
Prev Profitabilities > 2
70
Prev Risks > 0
-518
Prev Risks > 1
-664
Prev Risks > 2
-169
Prev Liquidities > 0
21
Prev Liquidities > 1
22
Prev Liquidities > 2
14
Updated At
2026-01-20T22:21:40.026Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-12-03
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.1
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-03
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.0167
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.0446
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2024-12-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.8717
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.0572
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.0241
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.0107
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.0153
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
0.0086
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
0.0333
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-03-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
0.0122
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AGrowth Review: Is Hyperfine Inc gaining market share - Trade Performance Summary & Low Risk High Win Rate Picks baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of OSR Holdings Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.1
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.